Motor disorders of the biliary tract: causes, consequences, forecast and long-term impact

April 19, 2024
654
УДК:  616.366
Specialities :
Resume

It is changes in the synchronism of the work of the gallbladder and the sphincter apparatus of the biliary system that underlie the formation of functional disorders of the biliary tract. Biliary pathology in Ukraine has taken a leading place in the gene­ral structure of gastroenterological diseases with a tendency towards an annual increase in the number of surgical interventions performed on the gallbladder and sphincter of Oddi. Timely diagnosis and treatment of functional biliary disorders are important both from the aspect of improving the well-being of patients and improving the quality of life, and from the position of their initial role in the further progression of diseases of the biliary tract up to the development of gallstone disease. Motor disorders of the biliary tract are not only the cause of a characteristic symptom complex that reduces the quality of life of patients, but also represent a complex problem, the treatment of which is a serious challenge for clinicians.

References

  • 1. Степанов Ю.М., Мосійчук Л.М., Дементій Н.П., Петішко О.П. (2016) Дискінезії жовчовивідних шляхів у хворих на виразкову хворобу дванадцатипалої кишки: можливості медика-ментозної корекції. Новини медицини та фармації, 10(584): 6–7.
  • 2. Louis-Jean S., Agrawal N., Chaudhry S., Mazer A. (2023) Biliary Dyskinesia in Stiff Person Syndrome: An Association Between Reduced GABA Production and Gastroenteric Dysmotility. J. Community Hosp. Intern. Med. Perspect, 13(5): 94–96. doi: 10.55729/2000-9666.1239.
  • 3. Kegnæs M., Novovic S., Shabanzadeh D.M. (2023) Dysfunction of Biliary Sphincter of Oddi-Clinical, Diagnostic and Treatment Challenges. J. Clin. Med., 12(14): 4802. doi: 10.3390/jcm12144802.
  • 4. Toouli J. (2002) Biliary Dyskinesia. Curr. Treat Options Gastroenterol., 5(4): 285–291. doi: 10.1007/s11938-002-0051-9.
  • 5. George J., Baillie J. (2007) Biliary and gallbladder dyskinesia. Curr. Treat Options Gastroenterol., 10(4): 322–327. doi: 10.1007/s11938-007-0075-2.
  • 6. Afghani E., Lo S.K., Covington P.S. et al. (2017) Sphincter of Oddi Function and Risk Factors for Dysfunction. Front. Nutr., 4: 1. doi: 10.3389/fnut.2017.00001.
  • 7. Catalano M.F., Howell D.A. (2021) Grover Shilpa Clinical Manifestations and Diagnosis of Sphincter of Oddi Dysfunction. UpToDate 2021. publishingimages.s3.amazonaws.com/eZineImages/PracticePerfect/726/Clinical-manifestations-and-diagnosis.pdf.
  • 8. Rosenblatt M.L., Catalano M.F., Alcocer E., Geenen J.E. (2001) Comparison of Sphincter of Oddi Manometry, Fatty Meal Sonography, and Hepatobiliary Scintigraphy in the Diagnosis of Sphincter of Oddi Dysfunction. Gastrointest. Endosc., 54: 697–704. doi: 10.1067/mge.2001.118946.
  • 9. Tanaka M. (2010) Function and Dysfunction of the Sphincter of Oddi. Dig. Surg., 27: 94–99. doi: 10.1159/000286464.
  • 10. Hauge C.W., Mark J.B. (1965) Common Bile Duct Motility and Sphincter Mechanism. I. Pressure Measurements with Multiple-Lumen Catheter in Dogs. Ann. Surg., 162: 1028–1038. doi: 10.1097/00000658-196512000-00009.
  • 11. Hedner P., Rorsman G. (1969) On the Mechanism of Action for the Effect of Cholecystokinin on the Choledochoduodenal Junction in the Cat. Acta. Physiol. Scand., 76: 248–254. doi: 10.1111/j.1748-1716.1969.tb04467.x.
  • 12. Presti M.E., Elwing J.E., Sayuk G.S. (2022) Gallbladder Dyskinesia. South Med. J., 115(11): 838–841. doi: 10.14423/SMJ.0000000000001466.
  • 13. Kegnæs M., Novovic S., Shabanzadeh D.M. (2023) Dysfunction of Biliary Sphincter of Oddi-Clinical, Diagnostic and Treatment Challenges. J. Clin. Med., 12(14): 4802. doi: 10.3390/jcm12144802.
  • 14. Kim J.V., Wu G.Y. (2022) Update on Sphincter of Oddi Dysfunction: A Review. J. Clin. Transl. Hepatol., 10: 515–521.
  • 15. Kalaitzakis E., Ambrose T., Phillips-Hughes J. et al. (2010) Management of Patients with Biliary Sphincter of Oddi Disorder without Sphincter of Oddi Manometry. BMC. Gastroenterol., 10. doi: 10.1186/1471-230X-10-124.
  • 16. Wang X., Zhang Z., Wu S.C. (2020) Health Benefits of Silybum marianum: Phytochemistry, Pharmacology, and Applications. J. Agric. Food Chem., 68(42): 11644–11664. doi: 10.1021/acs.jafc.0c04791.
  • 17. Осьодло Г.В., Бойчак М.П., Федорова О.О. (2022) Актуальні аспекти застосування Афосилу при коморбідній патології печінки. Гастроентерологія, 56(4): 26–28.
  • 18. Ткач С.М., Доготар В.Г. (2019) Ефективність та безпека комбінованої гепатопротекції при хронічних токсичних ураженнях печінки. Здоров’я України 21 сторіччя, 17(462): 40–41.
  • 19. Saénz Rodriguez T., García Giménez D., de la Puerta Vázquez R. (2002) Choleretic activity and biliary elimination of lipids and bile acids induced by an artichoke leaf extract in rats. Phytomedicine, 9(8): 687–693. doi: 10.1078/094471102321621278.
  • 20. Lattanzio V., Paul A.K., Lansalta V., Cardinali A. (2009) Globe artichoke: a functional food and source of nutraceutical ingredients. J. Funct. Foods, 1: 131–144.
  • 21. Amini M.R., Sheikhhossein F., Talebyan A. et al. (2022) Effects of Artichoke Supplementation on Liver Enzymes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clin. Nutr. Res., 11(3): 228–239.
  • 22. Mohamed A., Farag M.A. (2022) Therapeutic Potential of Artichoke in the Treatment of Fatty Liver: A Systematic Review and Meta-Analysis. J. Med. Food, 25(1).